BIOMAT Database Logo BIOMAT Database Logo

[Significance of determining neuraminic acid and seromucoid in eliciting activity of rheumatic heart process in patients with heart disease and circulatory insufficiency]. 1977

A A Martynov

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009438 Neuraminic Acids Nine-carbon deoxyamino SUGAR ACIDS that are substrates for NEURAMINIDASE. Their derivatives include SIALIC ACIDS. Acids, Neuraminic
D009961 Orosomucoid Acid Seromucoid,Seromucoid,Serum Sialomucin,alpha 1-Acid Glycoprotein,alpha 1-Acid Seromucoid,A(1)-Acid Seromucoid,Acid alpha 1-Glycoprotein,Alpha(1)-Acid Glycoprotein,alpha 1-Acid Glycoprotein (Acute Phase),alpha 1-Glycoprotein Acid,Acid alpha 1 Glycoprotein,Glycoprotein, alpha 1-Acid,Seromucoid, Acid,Seromucoid, alpha 1-Acid,Sialomucin, Serum,alpha 1 Acid Glycoprotein,alpha 1 Acid Seromucoid,alpha 1 Glycoprotein Acid
D005260 Female Females
D006331 Heart Diseases Pathological conditions involving the HEART including its structural and functional abnormalities. Cardiac Disorders,Heart Disorders,Cardiac Diseases,Cardiac Disease,Cardiac Disorder,Heart Disease,Heart Disorder
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012214 Rheumatic Heart Disease Cardiac manifestation of systemic rheumatological conditions, such as RHEUMATIC FEVER. Rheumatic heart disease can involve any part the heart, most often the HEART VALVES and the ENDOCARDIUM. Bouillaud Disease,Bouillaud's Disease,Bouillauds Disease,Disease, Bouillaud,Disease, Bouillaud's,Disease, Rheumatic Heart,Diseases, Rheumatic Heart,Heart Disease, Rheumatic,Heart Diseases, Rheumatic,Rheumatic Heart Diseases

Related Publications

A A Martynov
[Hemodynamics in patients with circulatory insufficiency depending on the activity of the rheumatic process].
February 1975, Kardiologiia,
A A Martynov
[Cardiac glycoside treatment of rheumatic heart disease with circulatory insufficiency].
October 1979, Vrachebnoe delo,
A A Martynov
[Immunologicalreactivity in rheumatic heart defects with circulatory insufficiency].
May 1979, Vrachebnoe delo,
A A Martynov
[Functional state of the thyroid gland in circulatory insufficiency in patients with rheumatic heart disease].
January 1974, Terapevticheskii arkhiv,
A A Martynov
[Liver biopsy and blood serum enzyme content in patients with rheumatic heart disease with circulatory insufficiency].
February 1975, Kardiologiia,
A A Martynov
[The use of Nerobol in the treatment of patients with rheumatic heart disease and circulatory insufficiency].
June 1968, Klinicheskaia meditsina,
A A Martynov
[Effect of glutamic acid on oxidative processes in circulatory insufficiency in patients with rheumatic heart defects].
August 1960, Terapevticheskii arkhiv,
A A Martynov
[Blood serum transaminase activity and urinary catecholamine content in patients with rheumatic heart failure with circulatory insufficiency].
January 1970, Voprosy revmatizma,
A A Martynov
[Functional state of erythrocytes in patients with rheumatic heart diseases and circulatory insufficiency].
January 1982, Terapevticheskii arkhiv,
A A Martynov
[Evaluation of the excretory function of the liver in patients with rheumatic heart disease and circulatory insufficiency].
February 1971, Kardiologiia,
Copied contents to your clipboard!